BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 5,330.00
-130.00 (-2.38%)
At close: Mar 9, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 540.26 billion as of March 9, 2026. Its market cap has increased by 11.16% in one year.
Market Cap
540.26B
Enterprise Value
193.78B
Revenue
115.09B
Ranking
n/a
PE Ratio
4.59
Stock Price
5,330.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 540.26B, a decrease of -50.21%. That is a compound annual growth rate of -19.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 540.26B | -2.56% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| T&L Co., Ltd. | 407.64B |
| Value Added Technology | 347.59B |
| Vieworks | 215.39B |
| Dongbang Medical | 147.37B |
| Shinhung | 128.30B |
| CLASSYS | 3,612.94B |
| EOFLOW | 51.11B |
| PCL, Inc. | 17.87B |